Table 1 Baseline characteristic of CAD patients with impaired kidney disease
| Â | Overall | Non-MACE | MACE | P | |
|---|---|---|---|---|---|
n | 1640 | 1316 | 324 | Â | |
Male (%) | 670 (40.9) | 531 (40.3) | 139 (42.9) | 0.439 | |
Age, y | 69.40 [62.88, 75.90] | 69.10 [62.40, 75.60] | 70.30 [64.88, 77.32] | 0.005 | |
BMI, kg/m2 | 25.70 [23.53, 27.73] | 25.65 [23.59, 27.68] | 25.95 [23.31, 27.95] | 0.469 | |
Clinical presentation | |||||
 ACS (%) | 1116 (68.0) | 876 (66.6) | 240 (74.1) | 0.011 | |
 DM (%) | 1040 (63.4) | 793 (60.3) | 247 (76.2) |  < 0.001 | |
 Dyslipidemia (%) | 1283 (78.2) | 1029 (78.2) | 254 (78.4) | 0.996 | |
 HBP (%) | 1341 (81.8) | 1079 (82.0) | 262 (80.9) | 0.696 | |
 Family History CAD (%) | 160 (9.8) | 124 (9.4) | 36 (11.1) | 0.416 | |
 Smoking (%) | 858 (52.3) | 689 (52.4) | 169 (52.2) | 0.999 | |
Medications at discharge | |||||
 ARB.ACEI (%) | 516 (31.5) | 424 (32.2) | 92 (28.4) | 0.207 | |
 CCB (%) | 859 (52.4) | 692 (52.6) | 167 (51.5) | 0.784 | |
 NIT (%) | 1572 (95.9) | 1272 (96.7) | 300 (92.6) | 0.002 | |
 beta (%) | 1472 (89.8) | 1179 (89.6) | 293 (90.4) | 0.73 | |
 statin (%) | 1613 (98.4) | 1301 (98.9) | 312 (96.3) | 0.003 | |
 Aspirin (%) | 1624 (99.0) | 1303 (99.0) | 321 (99.1) | 1 | |
 Clopidogrel (%) | 1619 (98.7) | 1303 (99.0) | 316 (97.5) | 0.065 | |
 Ticagrelor (%) | 288 (17.6) | 229 (17.4) | 59 (18.2) | 0.794 | |
Laboratory data | |||||
 CR | 1.36 [1.18, 1.52] | 1.36 [1.18, 1.50] | 1.41 [1.22, 1.58] | 0.001 | |
 eGFR, mL/min/1.73 m2 | 53.16 [46.58, 56.90] | 53.42 [47.35, 57.03] | 51.94 [41.45, 56.38] |  < 0.001 | |
 HbA1C, % | 6.50 [5.90, 7.50] | 6.40 [5.90, 7.40] | 6.80 [6.00, 8.00] |  < 0.001 | |
 ApoA1, mmol/L | 1.32 [1.14, 1.50] | 1.34 [1.16, 1.51] | 1.27 [1.11, 1.43] |  < 0.001 | |
 ApoB, mmol/L | 0.76 [0.63, 0.92] | 0.76 [0.62, 0.91] | 0.78 [0.64, 0.96] | 0.06 | |
 ApoB/ApoA1 | 0.58 [0.47, 0.72] | 0.57 [0.46, 0.70] | 0.61 [0.50, 0.78] |  < 0.001 | |
 TC, mmol/L | 3.96 [3.36, 4.74] | 3.96 [3.36, 4.68] | 4.02 [3.36, 4.98] | 0.159 | |
 TG, mmol/L | 1.63 [1.21, 2.24] | 1.63 [1.23, 2.21] | 1.69 [1.17, 2.29] | 0.805 | |
 LDL, mmol/L | 2.31 [1.82, 2.99] | 2.30 [1.81, 2.95] | 2.43 [1.85, 3.18] | 0.08 | |
 HDL, mmol/L | 1.07 [0.89, 1.26] | 1.08 [0.89, 1.26] | 1.00 [0.87, 1.20] | 0.003 | |
 UA, mmol/L | 406.88 [345.70, 484.60] | 405.00 [343.37, 484.39] | 416.28 [355.95, 487.52] | 0.146 | |
 HBG, g/dL | 4.44 [4.03, 4.91] | 4.48 [4.08, 4.92] | 4.32 [3.84, 4.80] |  < 0.001 | |
 PLT, K/uL | 222.00 [182.00, 266.00] | 222.50 [183.00, 268.00] | 217.00 [181.75, 260.00] | 0.185 | |
 WBC, K/uL | 6.95 [5.86, 8.34] | 6.81 [5.77, 8.18] | 7.40 [6.28, 9.02] |  < 0.001 | |
Angiographic and PCI data | |||||
 Heavily calcified (%) | 91 (5.5) | 67 (5.1) | 24 (7.4) | 0.135 | |
 LM (%) | 73 (4.5) | 61 (4.6) | 12 (3.7) | 0.563 | |
 LAD (%) | 643 (39.2) | 520 (39.5) | 123 (38.0) | 0.654 | |
 LCX (%) | 244 (14.9) | 206 (15.7) | 38 (11.7) | 0.091 | |
 RCA (%) | 642 (39.1) | 502 (38.1) | 140 (43.2) | 0.108 | |
 Syntax | 13.00 [7.00, 20.50] | 13.00 [7.00, 20.00] | 14.00 [8.00, 22.00] | 0.076 | |
 MLD, mm | 0.30 [0.04, 0.50] | 0.30 [0.12, 0.50] | 0.28 [0.00, 0.46] | 0.002 | |
 TIMI (%) | 0 | 336 (20.5) | 246 (18.7) | 90 (27.8) | 0.004 |
1 | 62 (3.8) | 50 (3.8) | 12 (3.7) | Â | |
2 | 170 (10.4) | 138 (10.5) | 32 (9.9) | Â | |
3 | 1072 (65.4) | 882 (67.0) | 190 (58.6) | Â | |
 B2_C_lesion (%) | 1218 (74.3) | 956 (72.6) | 262 (80.9) | 0.003 | |
 Lesion length, mm | 25.00 [15.00, 39.00] | 24.00 [15.00, 39.00] | 26.00 [16.00, 40.00] | 0.288 | |
 Concentric (%) | 264 (16.1) | 219 (16.6) | 45 (13.9) | 0.261 | |
 Stent length, mm | 28.00 [18.00, 41.25] | 29.00 [18.00, 42.00] | 26.00 [18.00, 38.00] | 0.01 | |
 Stent (%) | 1457 (88.8) | 1184 (90.0) | 273 (84.3) | 0.005 | |